Lonza: 'We are platform and modality agnostic'
Earlier this month, Lonza acquired fellow biotech company Synaffix, to enhance and extend its integrated antibody-drug conjugates (ADCs) offering.
Archives for June 20, 2023
Saudi Arabia’s PIF launches ‘Lifera’ to elevate pharma manufacturing in Kingdom
Saudi Arabia’s Public Investment Fund (PIF) has launched a new commercial-scale contract development and manufacturing organization (CDMO) called Lifera.
Vera Therapeutics announces ‘positive’ clinical trial results for kidney disease treatment
Vera Therapeutics, a late-stage biotech company focused on developing treatments for patients with serious immunological diseases, has announced the results of its phase 2 clinical trial of atacicept for the treatment of IgA nephropathy (IgAN).